Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News GlaxoSmithKline creates new unit to support poorer countries

GlaxoSmithKline creates new unit to support poorer countries

5th July 2010

GlaxoSmithKline has created a new business unit which will consolidate activities targeted towards improving healthcare in developing nations.

The firm’s developing countries and market access operating unit is to be headed by Duncan Learmouth as of August 1st 2010 and will be focused on developing strategies to provide medicines to the world’s least developed countries.

It will integrate all of GlaxoSmithKline’s current pharmaceutical business in developing nations into one group, including access programmes and policies.

This comes as part of a wider commitment by the firm to improve healthcare in poorer countries, having recently reduced the prices of its patented medicines in these nations by an average of 45 per cent.

Andrew Witty, chief executive officer of GlaxoSmithKline, said: “Access to medicines continues to become hardwired into the way we do our business as we seek new solutions to challenges in all the communities in which we operate.”

Last month, GlaxoSmithKline was named top of the second annual Access of Medicines Index, thanks to the various measures and structures it has in place to provide wide access to its healthcare options.

We currently have 7 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.